Dyne Therapeutics, Inc.

DYN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $2.9B · 258 employees
96
SEC Filings
$18.63
Close 2026-06-01
258
Employees

Business Summary

Government regulationPatent term restoration and extension in this Annual Report on Form 10-K. In the future, if and when any product candidates we may develop receive FDA approval, we expect to apply for patent term extensions on issued patents covering those product candidates. Moreover, we intend to seek patent term adjustments and extensions for any of our issued patents in any jurisdiction where such adjustments and extensions are available. However, there is no guarantee that the applicabl...

Latest Stock Quote

DYN 2026-06-01 $18.63 O:$19.15 H:$19.185 L:$18.17 Vol:1.4M VWAP:$18.6275
origin leaf: 5bfd20d5ce0d5c40f6877d11c3723d984aa6cb4adbf3a890d010a8371057b7f6

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001193125-26-084178EDGAR117K words
2025-02-272024-12-310000950170-25-028356EDGAR
2024-03-052023-12-310000950170-24-025402EDGAR
2023-03-022022-12-310000950170-23-005708EDGAR
2022-03-102021-12-310000950170-22-003290EDGAR
2021-03-042020-12-310001564590-21-010726EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266882EDGAR76K words
2025-07-282025-06-300000950170-25-099161EDGAR
2025-05-082025-03-310000950170-25-066386EDGAR
2024-11-122024-09-300000950170-24-124572EDGAR
2024-08-122024-06-300000950170-24-095527EDGAR
2024-05-022024-03-310000950170-24-052066EDGAR
2023-10-302023-09-300000950170-23-056121EDGAR
2023-08-032023-06-300000950170-23-037585EDGAR
2023-05-112023-03-310000950170-23-020839EDGAR
2022-11-032022-09-300000950170-22-021546EDGAR
2022-08-042022-06-300000950170-22-014474EDGAR
2022-05-022022-03-310000950170-22-006860EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001193125-26-084207EDGAR2K words
2026-01-120001193125-26-009782EDGAR
2025-12-230001193125-25-329511EDGAR
2025-12-100001193125-25-314249EDGAR
2025-12-080001193125-25-311221EDGAR
2025-12-080001193125-25-310516EDGAR
2025-11-050001193125-25-266979EDGAR
2025-10-020001193125-25-228317EDGAR
2025-08-040000950170-25-101620EDGAR
2025-07-280000950170-25-099184EDGAR

96 total filings indexed. 68 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001818794
TickerDYN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.dyne-tx.com
Listed2020-09-17

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 60178ea46fcfc9f6c3772d59a404126308e5b15344dabc7997b2f4187a77a15f
parent: bb08e0c6327637f4d514a9519c9a9e0c54a99a8b6bbc6c2f7b32e52087a0a1ce
content hash: 4b4b5ead1439a0c10eb7c3cd7cdd98d150a93c174e3bf6634edabdfe3323e74e
signed: 2026-06-02T19:00:55.956Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf